SLS Sellas Life Sciences group - arbitrator dismisses company's claims in arbitration against 3d Medicines on July 24, 2026 - SEC filing - C
SLS Sellas Life Sciences group - arbitrator dismisses company's claims in arbitration against 3d Medicines on July 24, 2026 - SEC filing - Company to pay about $1M of 3d Medicines' legal fees - SEC filing